Evaluation of Ivermectin vs Permethrin for Treating Scabies-Summary of a Cochrane Review
Stefanie Rosumeck1, Alexander Nast1, Corinna Dressler1
1Division of Evidence-Based Medicine, Department of Dermatology, Venereology, and Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Clinical Question:
Is the use of ivermectin in patients infested with scabies associated with improved clinical and safety outcomes compared with permethrin?
Bottom Line:
Both ivermectin and permethrin treatment were associated with high clearance rates. There is low-certainty evidence that ivermectin was associated with slightly lower rates of complete clearance after 1 week compared with permethrin, 5%, cream (relative risk [RR], 0.65; 95% CI, 0.54-0.78). After 2 weeks, there was no difference in efficacy (RR, 0.91; 95% CI, 0.76-1.08; low-certainty evidence), or in the number of participants with adverse events (week 4: RR, 1.30; 95% CI, 0.35-4.83; low-certainty evidence).
Related Concept Videos
Cochran's Q Test
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Self-Evaluation: Self-Enhancement and Self-Verification


